68Ga-Pentixafor

DRUG7 trials

Conditions

CXCR4Cushing s SyndromeHematological MalignancyLeukemiaLymphomaMultiple MyelomaPET/CTPositron-Emission Tomography

Early Phase 1

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

NCT03436342

Peking Union Medical College HospitalLymphoma, Multiple Myeloma

Start: 2019-06-01End: 2020-12-01Target: 100Updated: 2019-12-27

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

RecruitingNCT04504526

First Affiliated Hospital of Fujian Medical UniversityLeukemia, Lymphoma, Multiple Myeloma

Start: 2020-08-07End: 2027-12-31Target: 50Updated: 2026-07-21

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

NCT05364177

Peking Union Medical College HospitalMultiple Myeloma

Start: 2021-08-11End: 2024-08-31Target: 100Updated: 2022-05-06

Application of 68Ga-Pentixafor PET/CT for Thymoma

NCT06086327

Peking Union Medical College HospitalThymoma

Start: 2023-06-22End: 2024-12-31Target: 100Updated: 2023-10-17

Phase 1

Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

RecruitingNCT07350707

Peking Union Medical College HospitalCushing s Syndrome

Start: 2023-06-12End: 2027-02-12Target: 160Updated: 2026-01-20

Unknown Phase

Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE

RecruitingNCT05188872

First Affiliated Hospital of Fujian Medical UniversityPositron-Emission Tomography

Start: 2020-09-01End: 2027-09-01Target: 100Updated: 2026-07-21

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

RecruitingNCT05255926

Zhongnan HospitalCXCR4, Hematological Malignancy, PET/CT

Start: 2022-03-01End: 2026-12-31Target: 300Updated: 2025-06-26

Related Papers

Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma

EJNMMI Research2025-06-20

An Occult Primary Thymic Mucosa‐Associated Lymphoid Tissue Lymphoma With Sjögren's Syndrome Revealed by <scp>CXCR4</scp> Targeted <scp>68Ga</scp>‐Pentixafor <scp>PET</scp>/<scp>CT</scp>

Journal of Cellular and Molecular Medicine2025-01-31

Comparative Analysis of Single-Path and Multipath Adrenal Venous Sampling in Primary Aldosteronism

Journal of Interventional Cardiology2023-08-121 citations

Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT.

2019-11-2772 citations